-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Dn73e0l/3A9pkSLiYGIbOqHyjP5nnO1MLNjGxS+zUHwAsCdbkGMgQtu11b2iBxxJ xJNFkpftX56IkxvN6MSdGg== 0001127602-10-012696.txt : 20100430 0001127602-10-012696.hdr.sgml : 20100430 20100430195829 ACCESSION NUMBER: 0001127602-10-012696 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100428 FILED AS OF DATE: 20100430 DATE AS OF CHANGE: 20100430 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GALLAGHER MICHAEL R CENTRAL INDEX KEY: 0001158587 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10269 FILM NUMBER: 10789434 MAIL ADDRESS: STREET 1: C/O PLAYTEX PRODUCTS INC STREET 2: 300 NYALA FARMS ROAD CITY: WESTPORT STATE: CO ZIP: 06880 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALLERGAN INC CENTRAL INDEX KEY: 0000850693 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 951622442 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 DUPONT DRIVE CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 7142464500 MAIL ADDRESS: STREET 1: P.O. BOX 19534 CITY: IRVINE STATE: CA ZIP: 92713-9534 4 1 form4.xml PRIMARY DOCUMENT X0303 4 2010-04-28 0000850693 ALLERGAN INC AGN 0001158587 GALLAGHER MICHAEL R 2525 DUPONT DRIVE IRVINE CA 92612 1 Common Stock 2010-04-29 4 A 0 14400 A 65200 D Phantom Stock Units 2010-04-28 4 A 0 16.41 60.95 A Common Stock 16.41 15813.89 D Phantom Stock Units 2010-04-28 4 A 0 16.41 60.95 A Common Stock 16.41 15830.3 D Nonemployee Director Stock Option (Right to Buy) 61.98 2010-04-29 4 A 0 11400 61.98 A 2020-04-29 Common Stock 11400 11400 D Phantom Stock Units 2010-04-29 4 A 0 32.27 61.98 A Common Stock 32.27 15862.57 D Restricted Stock granted to Nonemployee Directors under the Allergan, Inc. 2008 Incentive Award Plan. Stock vests at the rate of 4,800 shares each calendar year upon the earlier to occur (i) the first anniversary of the grant date, or (ii) the annual meeting held during such calendar year at which one or more members of the board are standing for re-election following the date of grant. Converts to common stock on a 1-for-1 basis. Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program in lieu of cash for meeting fees. Phantom stock units are to be settled 100% in stock upon the reporting person's retirement as an Allergan, Inc. director. Option is fully vested and exercisable upon the earlier to occur (i) the first anniversary of the grant date, or (ii) the annual meeting held during such calendar year at which one or more members of the board are standing for re-election following the date of grant. /s/ Matthew J. Maletta, Attorney-in-Fact for Michael R. Gallagher 2010-04-30 -----END PRIVACY-ENHANCED MESSAGE-----